Contact Us

TOURISM NEWS

Latest Updates of Viva Biotech's Portfolio Companies

Oct 31, 2024

HONG KONG,Oct. 30,2024-- Even with the ever-changing situation,technological innovation is still the most critical component for biopharmaceutical companies\' long-term development. This continuous in

Nagarro fortifies its UK footprint with the strategic acquisition of FWD View Limited

Oct 31, 2024

MUNICH,Oct. 30,2024--Nagarro,a global leader in digital engineering,announced today the acquisition of FWD View Limited,a UK-based specialist in financial market data transformations and visualizatio

The 2024 Asia Green and Low-Carbon Development Roundtable was held

Oct 31, 2024

QINGDAO,China,Oct. 31,2024-- On October 24,the Smart Energy Sub-forum of the Third Belt and Road Energy Ministerial Conference and 2024 Asia Green and Low-Carbon Development Roundtable was held inQing

TIER IV's AI Pilot system certified for Level 4 autonomous bus service in Nagano Prefecture

Oct 31, 2024

TOKYO,Oct. 31,2024--TIER IV,the pioneering force behind the world\'s first open-source software for autonomous driving,is proud to announce Level 4*1certification for the AI Pilot*2 system powering a

Singtel Recognized by Frost & Sullivan for Innovation, Boosting Enterprise Digital Transformation, and Market Leadership

Oct 29, 2024

Singtel is a strong homegrown brand pushing the boundaries of network slicing and advanced connectivity solutions globally

Lilly's Mounjaro® (tirzepatide) Approved in Hong Kong in KwikPen® Presentation for Chronic Weight Management and Type 2 Diabetes, Offering a New Option for the Treatment of Obesity, Overweight and Type 2 Diabetes

Oct 29, 2024

Adults taking Mounjaro in a clinical trial lost on average 48 lb. at the highest dose1,2 Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials6-12

1 ... 246 247 248 249 250 251 252 ... 368